| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 298,183 | 299,644 | 303,904 | 329,300 | | Cost of Revenue | 204,035 | 217,020 | 217,703 | 212,026 | | | Gross Profit | 94,148 | 82,624 | 86,201 | 117,274 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,117 | 9,959 | 9,307 | 9,734 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 33,757 | 28,145 | 28,272 | 27,350 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,274 | 44,520 | 48,622 | 80,190 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 706 | 238 | 495 | 857 | | Earnings Before Interest And Taxes | 48,980 | 44,758 | 49,117 | 81,047 | | Interest Expense | 7,383 | 7,675 | 7,808 | 7,981 | | Income Before Tax | 41,597 | 37,083 | 41,309 | 73,066 | | Income Tax Expense | (103) | 586 | (201) | 426 | | Minority Interest | 42 | (232) |
-
|
-
| | | | Net Income From Continuing Ops | 41,742 | 36,265 | 41,510 | 72,640 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,742 | 36,265 | 41,510 | 72,640 | | Preferred Stock And Other Adjustments |
-
| 179 | (50) | (129) | | | Net Income Applicable To Common Shares | $41,742 | $36,444 | $41,460 | $72,511 |
|
0.35% Nasdaq 
Income Statement
